Global Kinetics’ Personal KinetiGraph® (PKG®) Digital Wearable Technology Featured in Ten Posters at the International Congress of Parkinson’s Disease and Movement Disorders
September 20, 2019 09:00 ET
|
Global Kinetics Corporation
Results of new studies add to the growing body of data supporting the PKG as an important continuous, objective measure of movement for optimized management of Parkinson’s Disease PORTSMOUTH, N.H....
Data Published in Functional Neurology Demonstrate that Global Kinetics’ Personal KinetiGraph® (PKG®) is Uniquely Positioned to Enable Objective Assessment of Motor Fluctuations in Parkinson’s Disease Patients
July 23, 2019 09:00 ET
|
Global Kinetics Corporation
Unlike patient-reported motor diaries, PKG distinguishes among different groups of fluctuators and identifies high levels of dyskinesia among patients who deny having dyskinesia symptoms PORTSMOUTH,...
Data Published in Sensors Supports the Use of Global Kinetics’ Personal KinetiGraph® for Objective Assessment of Parkinson’s Disease Patients Who May Benefit From Device-Assisted Therapies
June 04, 2019 09:00 ET
|
Global Kinetics Corporation
Novel screening tool provides first objective assessment for managing referral for device-assisted therapy (DAT), including deep brain stimulation (DBS) and infusion therapies, and has potential to...
Global Kinetics Corporation’s PKG® Provides Clinically Meaningful Improvement in Symptom Assessment, Management, Medication Optimization, and Patient-Clinician Conversations in Parkinson’s Disease
May 07, 2019 09:00 ET
|
Global Kinetics Corporation
Data Recently Presented at the 2019 American Academy of Neurology’s Annual Meeting APPRISE Clinical Study Continues Enrollment at 10 Movement Disorder Clinics in the U.S. PORTSMOUTH, N.H. and LONDON...
Global Kinetics Corporation Appoints Greg Barrett As Independent Director to its Board of Directors
April 02, 2019 09:00 ET
|
Global Kinetics Corporation
PORTSMOUTH, N.H. and MELBOURNE, Australia, April 02, 2019 (GLOBE NEWSWIRE) -- Global Kinetics Pty Ltd., a medical device company focused on the development and commercialization of the first...
Data Published in the Journal of Parkinson’s Disease Demonstrate Real-World Clinical Benefit of Global Kinetics’ Personal KinetiGraph® in Optimizing Parkinson’s Disease Therapy
February 04, 2019 09:00 ET
|
Global Kinetics Corporation
- Additional monitoring data helped clinicians optimize drug therapy in nearly one-third of study patients - PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia and MOUNTAIN VIEW, Calif., Feb. 04,...
Global Kinetics Corporation’s PKG® Smartwatch Provides Clinically Meaningful Improvement in Parkinson’s Disease Symptom Assessment, Management and Medication Optimization, As Well As Projected Per Patient Cost Savings
November 02, 2018 09:00 ET
|
Global Kinetics Corporation
Data Recently Presented at the 2018 International Congress of Parkinson’s Disease and Movement Disorders PORTSMOUTH, N.H., LONDON and MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Global...
Company update: Global Kinetics Corporation hits significant clinical milestones on its trajectory to revolutionise the treatment of Parkinson’s disease
August 21, 2018 09:00 ET
|
Global Kinetics Corporation
Leading digital health company Global Kinetics’ ground-breaking PKG™ technology recommended by world leading Parkinson’s experts ahead of achieving a key milestone on the path to USA reimbursement ...
Global Kinetics Corporation’s Personal KinetiGraph™ Welcomes New Category III CPT® Codes for Use in Parkinson’s Care
July 31, 2018 17:00 ET
|
Global Kinetics Corporation
Leading Parkinson’s measurement company Global Kinetics reaches major milestone with issue of US CPT III codes PORTSMOUTH, N.H. and LONDON and MELBOURNE, Australia, July 31, 2018 (GLOBE NEWSWIRE)...
Global Kinetics Corporation Ltd. awarded grants from Michael J. Fox Foundation, Shake It Up Australia Foundation and Parkinson’s Victoria to advance management and outcomes in Parkinson’s disease
April 11, 2018 09:00 ET
|
Global Kinetics Corporation
Treat-to-Target trial aims to change the practice of care through advanced use of objective targets derived from an FDA-cleared PKG™ wearable technology PORTSMOUTH, N.H. and MELBOURNE,...